Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11424207 | 0.97 | CYP2D6 (0.30) | CYP2D6 | |
| SCHEMBL11242160 | 0.97 | CYP2D6 (0.30) | CYP2D6 | |
| SCHEMBL11430858 | 0.97 | CYP2D6 (0.30) | CYP2D6 | |
| SCHEMBL22081148 | 0.88 | — | — | |
| SCHEMBL22081750 | 0.85 | — | — | |
| SCHEMBL4559131 | 0.82 | TSHR (0.33) | — | |
| SCHEMBL26368 | 0.82 | — | — | |
| SCHEMBL9514804 | 0.82 | — | — | |
| Methylamine SCHEMBL6868266 | 0.79 | TSHR (0.31) | — | |
| Hydrochloric Acid SCHEMBL2860424 | 0.79 | TSHR (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050155162-A1 | Process for the coloration of aluminium | CIBA SPECIALTY CHEMICALS CORP. | 2005-07-21 | — | — | US | claimed |
| US-6074978-A | WATER AND COMPOUND WITH LEWIS ACID COINITIATORS AND ORGANOMETAL PHENOXIDE HALIDE OR CARBOXYL HALIDES | EXXON CHEMICAL PATENTS INC. (US) | 2000-06-13 | — | — | US | claimed |
| US-10807970-B2 | Tetrahydropyran and thiopyran derivatives having multimodal activity against pain | ESTEVE PHARMACEUTICALS, S.A. (ES) | 2020-10-20 | — | — | US | disclosed |
| WO-2020115190-A1 | NOVEL ANTIBACTERIAL 3\"-DERIVATIVES OF 4,6-DISUBSTITUTED 2,5-DIDEOXYSTREPTAMINE AMINOGLYCOSIDE ANTIBIOTICS | AGILEBIOTICS B.V. (NL) | 2020-06-11 | — | — | WO | disclosed |
| US-20190241544-A1 | TETRAHYDROPYRAN AND THIOPYRAN DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN | ESTEVE PHARMACEUTICALS, S.A. (ES) | 2019-08-08 | — | — | US | disclosed |
| US-9656994-B2 | Substituted benzimidazoles as nociceptin receptor modulators | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-05-23 | — | — | US | disclosed |
| EP-1831315-B1 | DYES THAT ARE SOLUBLE IN ORGANIC SOLVENTS | BASF SE (DE) | 2011-08-03 | — | — | EP | disclosed |
| US-7517369-B2 | Coloring plastics using cationic dyes | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-04-14 | — | — | US | disclosed |
| US-7470780-B2 | Dyes that are soluble in organic solvents | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-12-30 | — | — | US | disclosed |
| US-20080319089-A1 | Method of colouring carrier materials | MULLER MARTIN | 2008-12-25 | — | — | US | disclosed |
| US-20080184497-A1 | Dyes That are Soluble in Organic Solvents | CIBA SPECIALTY CHEMICALS CORP. | 2008-08-07 | — | — | US | disclosed |
| US-20080103313-A1 | Dyes that are Soluble in Organic Solvents | CIBA SPECIALTY CHEMICALS CORP. | 2008-05-01 | — | — | US | disclosed |
| US-7217688-B2 | Methods and compositions for derepression of IAP-inhibited caspase | THE BURNHAM INSTITUTE (US) | 2007-05-15 | — | — | US | disclosed |
| US-20070051275-A1 | Method of colouring carrier materials | CIBA SPECIALTY CHEMICALS CORP. | 2007-03-08 | — | — | US | disclosed |
| US-6074978-A | WATER AND COMPOUND WITH LEWIS ACID COINITIATORS AND ORGANOMETAL PHENOXIDE HALIDE OR CARBOXYL HALIDES | EXXON CHEMICAL PATENTS INC. (US) | 2000-06-13 | — | — | US | disclosed |
| US-5703183-A | POLYMERIZATION CATALYSTS | EXXON CHEMICAL PATENTS INC. (US) | 1997-12-30 | — | — | US | disclosed |
| WO-1995009190-A1 | CARBOCATIONIC CATALYST AND PROCESS FOR ITS USE | EXXON CHEMICAL PATENTS INC. (US) | 1995-04-06 | — | — | WO | disclosed |
| US-4198520-A | Nonionic monomeric emulsion stabilizers | THE KENDALL COMPANY (US) | 1980-04-15 | — | — | US | disclosed |
| US-3960935-A | Nonionic monomeric emulsion stabilizers | THE KENDALL COMPANY (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190241544-A1 | TETRAHYDROPYRAN AND THIOPYRAN DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN | OPRD1, SIGMAR1, OPRK1 | CYP2D6 420/4885 |
| US-20080103313-A1 | Dyes that are Soluble in Organic Solvents | CAT, TYR, KIT | CYP2D6 842/4885 |
| US-20080184497-A1 | Dyes That are Soluble in Organic Solvents | CAT, TYR, KIT | CYP2D6 692/4885 |
| US-20080319089-A1 | Method of colouring carrier materials | CRYAA, SLC67A1, SOD3 | CYP2D6 2159/4885 |
| US-10807970-B2 | Tetrahydropyran and thiopyran derivatives having multimodal activity against pain | OPRD1, SIGMAR1, OPRK1 | CYP2D6 420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.